Annual EBITDA
-$15.66 M
-$1.94 M-14.15%
01 December 2023
Summary:
Bio-Path Holdings annual earnings before interest, taxes, depreciation & amortization is currently -$15.66 million, with the most recent change of -$1.94 million (-14.15%) on 01 December 2023. During the last 3 years, it has fallen by -$4.91 million (-45.63%). BPTH annual EBITDA is now -31355.82% below its all-time high of -$49.80 thousand, reached on 30 June 2004.BPTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.60 M
+$405.00 K+13.47%
01 September 2024
Summary:
Bio-Path Holdings quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.60 million, with the most recent change of +$405.00 thousand (+13.47%) on 01 September 2024. Over the past year, it has increased by +$391.00 thousand (+13.07%). BPTH quarterly EBITDA is now -5419.02% below its all-time high of $48.90 thousand, reached on 31 March 2007.BPTH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$12.25 M
+$629.00 K+4.89%
01 September 2024
Summary:
Bio-Path Holdings TTM earnings before interest, taxes, depreciation & amortization is currently -$12.25 million, with the most recent change of +$629.00 thousand (+4.89%) on 01 September 2024. Over the past year, it has increased by +$3.42 million (+21.82%). BPTH TTM EBITDA is now -185460.61% below its all-time high of -$6600.00, reached on 30 September 2004.BPTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPTH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +13.1% | +21.8% |
| 3 y3 years | -45.6% | -28.3% | -40.5% |
| 5 y5 years | -107.3% | -16.4% | -68.1% |
BPTH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.4% | at low | -28.3% | +50.4% | -40.5% | +27.5% |
| 5 y | 5 years | -107.3% | at low | -47.0% | +50.4% | -68.1% | +27.5% |
| alltime | all time | <-9999.0% | at low | -5419.0% | +50.4% | <-9999.0% | +27.5% |
Bio-Path Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.60 M(-13.5%) | -$12.25 M(-4.9%) |
| June 2024 | - | -$3.01 M(-17.6%) | -$12.88 M(-8.5%) |
| Mar 2024 | - | -$3.65 M(+21.9%) | -$14.07 M(-10.2%) |
| Dec 2023 | -$15.66 M(+14.2%) | -$2.99 M(-7.4%) | -$15.66 M(-5.7%) |
| Sept 2023 | - | -$3.23 M(-23.0%) | -$16.61 M(-1.6%) |
| June 2023 | - | -$4.20 M(-20.0%) | -$16.89 M(+7.9%) |
| Mar 2023 | - | -$5.25 M(+33.2%) | -$15.66 M(+14.1%) |
| Dec 2022 | -$13.72 M(+33.5%) | -$3.94 M(+12.5%) | -$13.72 M(-1.0%) |
| Sept 2022 | - | -$3.50 M(+18.0%) | -$13.86 M(+11.9%) |
| June 2022 | - | -$2.97 M(-10.5%) | -$12.38 M(+10.7%) |
| Mar 2022 | - | -$3.31 M(-18.7%) | -$11.19 M(+8.8%) |
| Dec 2021 | -$10.28 M(-4.4%) | -$4.08 M(+100.9%) | -$10.28 M(+17.9%) |
| Sept 2021 | - | -$2.03 M(+14.6%) | -$8.72 M(-9.4%) |
| June 2021 | - | -$1.77 M(-26.6%) | -$9.62 M(-2.4%) |
| Mar 2021 | - | -$2.41 M(-4.1%) | -$9.86 M(-8.3%) |
| Dec 2020 | -$10.76 M(+27.1%) | -$2.51 M(-14.3%) | -$10.76 M(+1.3%) |
| Sept 2020 | - | -$2.93 M(+46.2%) | -$10.62 M(+7.0%) |
| June 2020 | - | -$2.01 M(-39.3%) | -$9.92 M(-4.1%) |
| Mar 2020 | - | -$3.31 M(+39.3%) | -$10.34 M(+22.2%) |
| Dec 2019 | -$8.46 M(+12.0%) | -$2.37 M(+6.2%) | -$8.46 M(+16.2%) |
| Sept 2019 | - | -$2.23 M(-7.9%) | -$7.28 M(-9.2%) |
| June 2019 | - | -$2.43 M(+70.3%) | -$8.02 M(+11.9%) |
| Mar 2019 | - | -$1.43 M(+19.3%) | -$7.17 M(-5.1%) |
| Dec 2018 | -$7.56 M(-11.7%) | -$1.20 M(-59.8%) | -$7.56 M(-10.3%) |
| Sept 2018 | - | -$2.98 M(+89.1%) | -$8.42 M(+7.9%) |
| June 2018 | - | -$1.57 M(-13.2%) | -$7.81 M(-7.5%) |
| Mar 2018 | - | -$1.81 M(-12.1%) | -$8.45 M(-1.3%) |
| Dec 2017 | -$8.55 M(+3.4%) | -$2.06 M(-12.5%) | -$8.55 M(+5.5%) |
| Sept 2017 | - | -$2.36 M(+6.7%) | -$8.11 M(-6.7%) |
| June 2017 | - | -$2.21 M(+14.9%) | -$8.69 M(+3.8%) |
| Mar 2017 | - | -$1.92 M(+19.0%) | -$8.38 M(+1.3%) |
| Dec 2016 | -$8.27 M(+56.6%) | -$1.62 M(-45.1%) | -$8.27 M(+2.5%) |
| Sept 2016 | - | -$2.94 M(+55.5%) | -$8.07 M(+22.5%) |
| June 2016 | - | -$1.89 M(+4.1%) | -$6.59 M(+14.1%) |
| Mar 2016 | - | -$1.82 M(+28.7%) | -$5.77 M(+9.3%) |
| Dec 2015 | -$5.28 M(+20.9%) | -$1.41 M(-3.3%) | -$5.28 M(-2.6%) |
| Sept 2015 | - | -$1.46 M(+35.3%) | -$5.42 M(+6.8%) |
| June 2015 | - | -$1.08 M(-18.7%) | -$5.08 M(-3.0%) |
| Mar 2015 | - | -$1.33 M(-14.4%) | -$5.23 M(+19.6%) |
| Dec 2014 | -$4.37 M | -$1.55 M(+39.3%) | -$4.37 M(+22.5%) |
| Sept 2014 | - | -$1.11 M(-9.8%) | -$3.57 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$1.23 M(+162.6%) | -$3.81 M(+28.6%) |
| Mar 2014 | - | -$470.10 K(-37.4%) | -$2.96 M(-4.7%) |
| Dec 2013 | -$3.11 M(+29.7%) | -$750.80 K(-44.5%) | -$3.11 M(+13.1%) |
| Sept 2013 | - | -$1.35 M(+248.4%) | -$2.75 M(+25.7%) |
| June 2013 | - | -$388.50 K(-36.9%) | -$2.19 M(-13.8%) |
| Mar 2013 | - | -$615.80 K(+57.3%) | -$2.54 M(+5.9%) |
| Dec 2012 | -$2.40 M(+11.3%) | -$391.60 K(-50.6%) | -$2.40 M(-13.0%) |
| Sept 2012 | - | -$792.00 K(+7.1%) | -$2.76 M(+14.1%) |
| June 2012 | - | -$739.30 K(+55.8%) | -$2.42 M(+15.7%) |
| Mar 2012 | - | -$474.50 K(-36.8%) | -$2.09 M(-3.1%) |
| Dec 2011 | -$2.15 M(+1.2%) | -$750.40 K(+66.2%) | -$2.15 M(-4.7%) |
| Sept 2011 | - | -$451.50 K(+9.8%) | -$2.26 M(+0.0%) |
| June 2011 | - | -$411.10 K(-24.0%) | -$2.26 M(+1.5%) |
| Mar 2011 | - | -$541.00 K(-36.8%) | -$2.23 M(+4.6%) |
| Dec 2010 | -$2.13 M(+77.2%) | -$855.50 K(+89.6%) | -$2.13 M(+40.3%) |
| Sept 2010 | - | -$451.30 K(+19.2%) | -$1.52 M(+18.5%) |
| June 2010 | - | -$378.50 K(-14.7%) | -$1.28 M(-7.9%) |
| Mar 2010 | - | -$443.80 K(+82.2%) | -$1.39 M(+2.8%) |
| Dec 2009 | -$1.20 M(-55.9%) | -$243.60 K(+13.8%) | -$1.35 M(-54.3%) |
| Sept 2009 | - | -$214.00 K(-56.1%) | -$2.96 M(+0.3%) |
| June 2009 | - | -$487.80 K(+20.2%) | -$2.95 M(+0.7%) |
| Mar 2009 | - | -$405.90 K(-78.1%) | -$2.93 M(+7.5%) |
| Dec 2008 | -$2.72 M(+2434.4%) | -$1.85 M(+808.5%) | -$2.72 M(+151.2%) |
| Sept 2008 | - | -$203.70 K(-56.3%) | -$1.08 M(+20.3%) |
| June 2008 | - | -$466.10 K(+131.5%) | -$901.10 K(+68.9%) |
| Mar 2008 | - | -$201.30 K(-5.3%) | -$533.60 K(+88.3%) |
| Dec 2007 | - | -$212.50 K(+902.4%) | -$283.40 K(+181.2%) |
| Sept 2007 | - | -$21.20 K(-78.5%) | -$100.80 K(-6.1%) |
| June 2007 | -$107.40 K(-18.6%) | -$98.60 K(-301.6%) | -$107.40 K(+21.6%) |
| Mar 2007 | - | $48.90 K(-263.5%) | -$88.30 K(-43.7%) |
| Dec 2006 | - | -$29.90 K(+7.6%) | -$156.70 K(+12.2%) |
| Sept 2006 | - | -$27.80 K(-65.0%) | -$139.70 K(+5.8%) |
| June 2006 | -$132.00 K(+106.9%) | -$79.50 K(+307.7%) | -$132.00 K(+53.7%) |
| Mar 2006 | - | -$19.50 K(+51.2%) | -$85.90 K(+7.2%) |
| Dec 2005 | - | -$12.90 K(-35.8%) | -$80.10 K(+3.5%) |
| Sept 2005 | - | -$20.10 K(-39.8%) | -$77.40 K(+21.1%) |
| June 2005 | -$63.80 K(+28.1%) | -$33.40 K(+143.8%) | -$63.90 K(+109.5%) |
| Mar 2005 | - | -$13.70 K(+34.3%) | -$30.50 K(+81.5%) |
| Dec 2004 | - | -$10.20 K(+54.5%) | -$16.80 K(+154.5%) |
| Sept 2004 | - | -$6600.00 | -$6600.00 |
| June 2004 | -$49.80 K | - | - |
FAQ
- What is Bio-Path Holdings annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bio-Path Holdings?
- What is Bio-Path Holdings quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bio-Path Holdings?
- What is Bio-Path Holdings quarterly EBITDA year-on-year change?
- What is Bio-Path Holdings TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bio-Path Holdings?
- What is Bio-Path Holdings TTM EBITDA year-on-year change?
What is Bio-Path Holdings annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BPTH is -$15.66 M
What is the all time high annual EBITDA for Bio-Path Holdings?
Bio-Path Holdings all-time high annual earnings before interest, taxes, depreciation & amortization is -$49.80 K
What is Bio-Path Holdings quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BPTH is -$2.60 M
What is the all time high quarterly EBITDA for Bio-Path Holdings?
Bio-Path Holdings all-time high quarterly earnings before interest, taxes, depreciation & amortization is $48.90 K
What is Bio-Path Holdings quarterly EBITDA year-on-year change?
Over the past year, BPTH quarterly earnings before interest, taxes, depreciation & amortization has changed by +$391.00 K (+13.07%)
What is Bio-Path Holdings TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BPTH is -$12.25 M
What is the all time high TTM EBITDA for Bio-Path Holdings?
Bio-Path Holdings all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6600.00
What is Bio-Path Holdings TTM EBITDA year-on-year change?
Over the past year, BPTH TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.42 M (+21.82%)